Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp https://t.co/nPeP77VmWn https://t.co/Qxw2QT0FbV https://t.co/AkZYzrG5Sz https://t.co/nwYSHR68ku https://t.co/Z4mafPZa2m
Tumor-associated macrophages: an accomplice in solid tumor progression.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2021 – Aug 2025Where it's discussed
-
X / Twitter30 posts
-
YouTube2 videos
-
News2 articles
AI synopsis
What people are saying
The overall tone suggests a cautious recognition of the role of tumor-associated macrophages in cancer progression, with comments referencing industry developments such as biotech partnerships and pathways, like Macrophages and NK+M, indicating some engagement with translational or therapeutic implications. The language and references point to moderate interest but limited deep engagement with the core scientific findings.
The discussions reflect some skepticism about the immediate impact or application of the research, with little explicit support or disagreement.
Participants show moderate interest, particularly around related therapeutic strategies and industry developments, but some posts are more tangential.
The exchanges seem somewhat superficial, mainly referencing other sources or broad concepts without deep analysis.
The posts indicate awareness of the research's potential relevance but do not suggest it is causing significant shifts in thinking or practice yet.
Abstract in brief
- Tumor-associated macrophages (TAMs) are key players in the tumor microenvironment and are linked to poorer survival rates in patients with solid tumors.
- TAMs originate from immune cells and their behavior is influenced by the tumor microenvironment, which can cause them to support tumor growth, resistance to treatments, and metastasis through processes like promoting blood vessel formation and suppressing the immune response.
- Therapeutic approaches targeting TAMs include methods to eliminate or inhibit their activity, boost their ability to attack cancer cells, and prevent monocyte recruitment, aiming to improve treatment outcomes for solid tumor patients.]
Top posts
Most liked on X and Bluesky@ANACONDAFINANC1 @RNA_Biotech Prob no near term takeout given CEO "driver's seat" stated in Jeff webcast in answer tol afm13 partnerships question and not enough afm24 data til late next year. $tril got taken out for cd47/macrophages pathway. $afmd begets NK+M combo https://t.co/gqJHnE0N4r
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
All mentions
Role of Tumor-Associated Macrophages in Solid Tumor Progression and Therapy Resistance
Tumor-associated macrophages are key players in the tumor microenvironment and are linked to poorer survival rates in patients with solid tumors. They support tumor growth, resistance to treatments, and metastasis…
Role of Tumor-Associated Macrophages in Solid Tumor Progression
Tumor-associated macrophages (TAMs) are key players in the tumor microenvironment and are linked to poorer survival rates in patients with solid tumors. This video explores how TAMs support tumor growth, resistance, and…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…
Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp https://t.co/nPeP77VmWn https://t.co/Qxw2QT0FbV https://t.co/AkZYzrG5Sz https://t.co/nwYSHR68ku https://t.co/Z4mafPZa2m
RT @Long6422Da: @ANACONDAFINANC1 @RNA_Biotech Prob no near term takeout given CEO "driver's seat" stated in Jeff webcast in answer tol afm1…
@ANACONDAFINANC1 @RNA_Biotech Prob no near term takeout given CEO "driver's seat" stated in Jeff webcast in answer tol afm13 partnerships question and not enough afm24 data til late next year. $tril got taken out for cd47/macrophages pathway. $afmd begets NK+M combo https://t.co/gqJHnE0N4r
C